So there it is,they were getting low on funds; with a 1% royalty and repayable on demand.And sounds like they're having trouble finding mkts.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025